(Q30583015)

25 June 2017

1 reference

title

Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem (English)

1 reference

25 June 2017

0 references

cytomegaloviral disease

1 reference

Kuypers DR

1

1 reference

25 June 2017

Vanrenterghem YF

series ordinal

2

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Nephrology Dialysis Transplantation

25 June 2017

published in

1 reference

25 June 2017

volume

14

1 reference

25 June 2017

issue

10

1 reference

25 June 2017

page(s)

2304-2308

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Ganciclovir prophylaxis of cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F14.10.2304

21 January 2018

Identifiers

DOI

10.1093/NDT/14.10.2304

1 reference

25 June 2017

1 reference